| Name | 5-[[4-(3-phenylpropanoyl)phenyl]methyl]-1,3-thiazolidine-2,4-dione |
|---|---|
| Synonyms |
5-<4-(3-phenylpropionyl)benzyl>thiazolidine-2,4-dione
2,4-Thiazolidinedione,5-[[4-(1-oxo-3-phenylpropyl)phenyl]methyl] |
| Molecular Formula | C19H17NO3S |
|---|---|
| Molecular Weight | 339.40800 |
| Exact Mass | 339.09300 |
| PSA | 92.03000 |
| LogP | 3.67210 |
|
~82%
125734-22-7 |
| Literature: Pfizer Inc. Patent: US5061717 A1, 1991 ; |
|
~%
125734-22-7 |
| Literature: Hulin, Bernard; Clark, David A.; Goldstein, Steven W.; McDermott, Ruth E.; Dambek, Paul J.; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 10 p. 1853 - 1864 |
|
~%
125734-22-7 |
| Literature: Hulin, Bernard; Clark, David A.; Goldstein, Steven W.; McDermott, Ruth E.; Dambek, Paul J.; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 10 p. 1853 - 1864 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |